$16.87
-0.36-2.09%
In chiusura: Sep 18, 5:00 PM EST
$16.78
-0.09-0.53%
Post-mercato: 6:10 PM EST

Tandem Diabetes Care (TNDM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Tandem Diabetes Care (TNDM) ha pubblicato l'ultima guidance il agosto 6, 2026 per fiscal year 2026. La società ha previsto un fatturato pari a $1.06B - $1.08B per il periodo.
Rispetto alle previsioni precedenti, Tandem Diabetes Care ha modificato le sue previsioni di fatturato da un intervallo precedente di .
Tandem Diabetes Care ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il Tandem Diabetes Care. 20
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.33 | $-0.45 | $-0.07 | $-0.33 |
| Actual | $-0.31 | $-0.30 | $-0.01 | $-0.31 |
| Surprise | +6.06% | +33.3% | +85.7% | +6.06% |
| Revenue | ||||
| Estimate | $255.0M | $240.2M | $276.7M | $236.6M |
| Actual | $254.6M | $247.2M | $290.4M | $249.3M |
| Surprise | -0.16% | +2.91% | +4.93% | +5.36% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.25 | $0.18 | $-0.14 | $-0.09 |
| Revenue | ||||
| Consensus | $265.8M | $304.4M | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.31 | $-0.33 | 6.06 % |
| Q1 | May 7, 2026 | $-0.30 | $-0.45 | 33.3 % |
| Q4 | Feb 19, 2026 | $-0.01 | $-0.07 | 85.7 % |
| Q3 | Nov 6, 2025 | $-0.31 | $-0.33 | 6.06 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $254.56M | $254.97M | -0.16 % |
| Q1 | May 7, 2026 | $247.22M | $240.22M | 2.91 % |
| Q4 | Feb 19, 2026 | $290.40M | $276.74M | 4.93 % |
| Q3 | Nov 6, 2025 | $249.25M | $236.56M | 5.36 % |